✦ LIBER ✦

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

✍ Scribed by S E Harper; J L Dienstag

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 169 KB
Volume: 23
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510230439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Varying incidence of cirrhosis and hepat

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

✍ Michiko Shindo; Arai Ken; Tadao Okuno 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa

Risk factors for hepatocellular carcinom

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

✍ Akinori Kasahara; Norio Hayashi; Kiyoshi Mochizuki; Masahide Takayanagi; Kentaro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

To elucidate the risk factors for liver carcinogenesis and to examine the incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated with interferon were followed by ultrasonography for 13 to 97 months (median 36 months). Sustained response with

Lymphoproliferative responses to hepatit

Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa

✍ G Leroux-Roels; C A Esquivel; R DeLeys; L Stuyver; A Elewaut; J Philippé; I Deso 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Occult and previous hepatitis B virus in

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

✍ Anna S. Lok; James E. Everhart; Adrian M. Di Bisceglie; Hae-Young Kim; Munira Hu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

Previous studies have suggested that prior exposure to hepatitis B virus (HBV) infection may increase the risk of development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. The aim of this study was to compare the prevalence of previous or occult HBV infection in a cohort of

Occult hepatitis B virus infection is as

Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients

✍ Giovanni Squadrito; Teresa Pollicino; Irene Cacciola; Gaia Caccamo; Daniela Vill 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Hepatic steatosis in patients with chron

Hepatic steatosis in patients with chronic hepatitis C virus infection : Another risk factor for hepatocellular carcinoma?

✍ Andrew X. Zhu; Raymond T. Chung 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

## Abstract DOI 10.1002/cncr.11440